substance P;
phospholipase D;
protein kinase C;
NK1;
receptor;
Chinese hamster ovary cells;
human astrocytoma cells;
D O I:
暂无
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
In [H-3]myristic acid-prelabeled Chinese hamster ovary cells stably expressing the rat NK1 tachykinin receptor, the selective NK1 agonist [Pro(9)]substance P ([Pro(9)]SP) time and concentration dependently stimulated the formation of [H-3]phosphatidylethanol in the presence of ethanol. This [Pro(9)]SP-induced activation of phospholipase D (PLD) was blocked by NK1 receptor antagonists and poorly or not mimicked by NK2 and NK3 agonists, respectively. In confirmation of previous observations, [Pro(9)]SP also stimulated the hydrolysis of phosphoinositides, the release of arachidonic acid, and the formation of cyclic AMP (cAMP). All these [Pro(9)]SP-evoked responses could be mimicked by aluminum fluoride, but they remained unaffected in cells pretreated with pertussis toxin, suggesting that a G(i)/G(o) protein is not involved in these different signaling pathways. The activation of PLD by [Pro(9)]SP was sensitive to external calcium and required an active protein kinase C because the inhibition of this kinase (Ro 31-8220) or its down-regulation (long-term treatment with a phorbol ester) abolished the response. In contrast, a cAMP-dependent process was not involved in the activation of PLD because the [Pro(9)]SP-evoked response was neither affected by Rp-8-bromoadenosine 3',5'-cyclic monophosphorothioate nor mimicked by cAMP-generating compounds (cholera toxin or forskolin) or by 8-bromo-cyclic AMP. A functional coupling of NK1 receptors to PLD was also demonstrated in the human astrocytoma cell line U 373 MG stimulated by SP or [Pro(9)]SP. These results suggest that PLD activation could be an additional signaling pathway involved in the mechanism of action of SP in target cells expressing NK1 receptors.
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
DELUMEAU, JC
PETITET, F
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
PETITET, F
CORDIER, J
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
CORDIER, J
GLOWINSKI, J
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
GLOWINSKI, J
PREMONT, J
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
机构:
ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIAROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA
DENIZOT, F
LANG, R
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIAROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
DELUMEAU, JC
PETITET, F
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
PETITET, F
CORDIER, J
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
CORDIER, J
GLOWINSKI, J
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
GLOWINSKI, J
PREMONT, J
论文数: 0引用数: 0
h-index: 0
机构:
COLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCECOLL FRANCE,NEUROPHARMACOL LAB,CHAIRE NEUROPHARMACOL,INSERM,U114,11 PL M BERTHELOT,F-75231 PARIS 05,FRANCE
机构:
ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIAROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA
DENIZOT, F
LANG, R
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIAROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA